Ganirelix

• TRAP study: Testosterone for Androgen Receptor Polymorphism. Not authorised
  2024-510596-37-00 Phase IV 1 country Instituto Bernabeu S.L.
• MENOPUR and REKOVELLE in Women UnderGoing an assisted reproductive technology cycle Pending
  2022-500308-23-00 Phase III/IV 2 countries Ferring Pharmaceuticals A/S
• TRAP study: Testosterone for Androgen Receptor Polymorphism. Pending
  2024-510596-37-01 Phase III 1 country Instituto Bernabeu S.L.
• Effect of Semaglutide on embryo quality in overweight and obese patients undergoing In Vitro Fertilization. A Randomized Controlled Trial Recruiting
  2025-522525-34-00 Phase IV 1 country Santiago Dexeus Font Fundacio Privada
• PPOS (Progestin primed ovarian stimulation) and Corifollitropin alfa (CFA) cross-over study Recruiting
  2023-506694-35-00 Phase IV 1 country Universitair Ziekenhuis Gent
• Protocol with Progestin-primed Ovarian Stimulation (PPOS) in conventional treatment from the start of stimulation vs protocol with GnRH anta… Recruiting
  2023-508769-33-00 Phase IV 1 country Ginefiv S.L.
• PRO_NAT Recruiting
  2023-504188-18-00 Phase IV 1 country Instituto Bernabeu S.L.
• A randomized comparison of one controlled ovarian stimulation with corifollitropin alfa (CFA) versus up to three modified natural cycles (MN… Recruiting
  2023-509094-23-00 Phase IV 1 country Universitair Ziekenhuis Gent
• The impact of the intensity of ovarian stimulation on embryo quality in predicted suboptimal responders. A randomized controlled trial. Ended
  2024-514322-23-00 Phase IV 1 country Santiago Dexeus Font Fundacio Privada

Showing 1–9 of 9 trials